---
document_datetime: 2023-09-21 18:38:35
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lyxumia-epar-all-authorised-presentations_en.pdf
document_name: lyxumia-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9979036
conversion_datetime: 2025-12-24 09:01:45.524493
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength      | Pharmaceutical Form    | Route of Administration   | Immediate Packaging          | Content (concentration)   | Pack size                           |
|------------------|-------------------|---------------|------------------------|---------------------------|------------------------------|---------------------------|-------------------------------------|
| EU/1/12/811/001  | Lyxumia           | 10 µg         | Solution for injection | Subcutaneous use          | cartridge in pre- filled pen | 3ml                       | 1 pre-filled pen                    |
| EU/1/12/811/002  | Lyxumia           | 20 µg         | Solution for injection | Subcutaneous use          | cartridge in pre- filled pen | 3ml                       | 1 pre-filled pen                    |
| EU/1/12/811/003  | Lyxumia           | 20 µg         | Solution for injection | Subcutaneous use          | cartridge in pre- filled pen | 3ml                       | 2 pre-filled pens                   |
| EU/1/12/811/004  | Lyxumia           | 20 µg         | Solution for injection | Subcutaneous use          | cartridge in pre- filled pen | 3ml                       | 6 pre-filled pens                   |
| EU/1/12/811/005  | Lyxumia           | 10 µg + 20 µg | Solution for injection | Subcutaneous use          | cartridge in pre- filled pen | 3ml                       | 1 pre-filled pen + 1 pre-filled pen |